Picture of IDL Diagnostics AB (publ) logo

IDLDX — IDL Diagnostics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: AroCell Improves Early Detection Of Ovarian Cancer With Algorithm

March 6 (Reuters) - AroCell AB (publ)  AROC.ST :
    * IMPROVED EARLY DETECTION OF OVARIAN CANCER WITH DUAL
BIOMARKER
ALGORITHM
    * RESULTS REVEAL THAT DUAL BIOMARKER COMBINATION OF TK 210 +
CA
125 OR TK 210 + HE4 HAS HIGHER SENSITIVITY FOR DETECTING
EARLY-STAGE OVARIAN CANCER AND SIGNIFICANTLY OUTPERFORMS ROMA
INDEX

Source text for Eikon:  ID:nMFN9cXjkJ 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on IDL Diagnostics AB (publ)

See all news